Demand for the drug has been falling with the loss of patent protection last year and as patients move to more effective and once-weekly treatments such as Novo’s Ozempic and Eli Lilly’s (LLY ...
Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high-quality generic drug products,” Dr. Iilun Murphy, the director of the ...